Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin in aMCI or Mild AD (SNIFF)
NCT01767909Phase 3Completed
- Sponsor
- University of Southern California
- Start
- Jan 2014
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of regular human insulin in Alzheimer's disease (AD), amnestic mild cognitive impairment (MCI), sponsored by University of Southern California. Started Jan 2014; status: completed.
02
Drugs
regular human insulin
03
Conditions
Alzheimer's disease (AD)amnestic mild cognitive impairment (MCI)
Beyond the preview
Go deeper on NCT01767909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01767909.